These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16256257)

  • 1. Factors involved in the determination of the neurotransmitter phenotype of developing neurons of the CNS: applications in cell replacement treatment for Parkinson's disease.
    Riaz SS; Bradford HF
    Prog Neurobiol; 2005 Jul; 76(4):257-78. PubMed ID: 16256257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering a dopaminergic phenotype in stem/precursor cells: role of Nurr1, glia-derived signals, and Wnts.
    Arenas E
    Ann N Y Acad Sci; 2005 May; 1049():51-66. PubMed ID: 15965107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
    Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
    Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model.
    Cai J; Donaldson A; Yang M; German MS; Enikolopov G; Iacovitti L
    Stem Cells; 2009 Jan; 27(1):220-9. PubMed ID: 18832589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of functional dopamine neurons from neural precursor cells isolated from the subventricular zone and white matter of the adult rat brain using Nurr1 overexpression.
    Shim JW; Park CH; Bae YC; Bae JY; Chung S; Chang MY; Koh HC; Lee HS; Hwang SJ; Lee KH; Lee YS; Choi CY; Lee SH
    Stem Cells; 2007 May; 25(5):1252-62. PubMed ID: 17234994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow stromal cells as replacement cells for Parkinson's disease: generation of an anatomical but not functional neuronal phenotype.
    Thomas MG; Stone L; Evill L; Ong S; Ziman M; Hool L
    Transl Res; 2011 Feb; 157(2):56-63. PubMed ID: 21256457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and adult neurogenesis.
    Borta A; Höglinger GU
    J Neurochem; 2007 Feb; 100(3):587-95. PubMed ID: 17101030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restorative approaches in Parkinson's Disease: which cell type wins the race?
    Meyer AK; Maisel M; Hermann A; Stirl K; Storch A
    J Neurol Sci; 2010 Feb; 289(1-2):93-103. PubMed ID: 19733367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current state of stem cell research for the treatment of Parkinson's disease.
    Gerlach M; Braak H; Hartmann A; Jost WH; Odin P; Priller J; Schwarz J
    J Neurol; 2002 Oct; 249 Suppl 3():III/33-5. PubMed ID: 12522570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of diverse neuronal subtypes in cloned populations of stem-like cells.
    Varga BV; Hádinger N; Gócza E; Dulberg V; Demeter K; Madarász E; Herberth B
    BMC Dev Biol; 2008 Sep; 8():89. PubMed ID: 18808670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem-cell-based strategies for the treatment of Parkinson's disease.
    Parish CL; Arenas E
    Neurodegener Dis; 2007; 4(4):339-47. PubMed ID: 17627139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell-based therapy for Parkinson's disease.
    Correia AS; Anisimov SV; Li JY; Brundin P
    Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease.
    O'Keeffe FE; Scott SA; Tyers P; O'Keeffe GW; Dalley JW; Zufferey R; Caldwell MA
    Brain; 2008 Mar; 131(Pt 3):630-41. PubMed ID: 18202103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell therapy for Parkinson's disease.
    Takahashi J
    Expert Rev Neurother; 2007 Jun; 7(6):667-75. PubMed ID: 17563250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural stem cells and neurodegeneration.
    Storch A; Schwarz J
    Curr Opin Investig Drugs; 2002 May; 3(5):774-81. PubMed ID: 12090552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta cooperates with persephin for dopaminergic phenotype induction.
    Roussa E; Oehlke O; Rahhal B; Heermann S; Heidrich S; Wiehle M; Krieglstein K
    Stem Cells; 2008 Jul; 26(7):1683-94. PubMed ID: 18420832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic properties and function after grafting of attached neural precursor cultures.
    Timmer M; Grosskreutz J; Schlesinger F; Krampfl K; Wesemann M; Just L; Bufler J; Grothe C
    Neurobiol Dis; 2006 Mar; 21(3):587-606. PubMed ID: 16256357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable expression of a neuronal dopaminergic progenitor phenotype in cell lines derived from human amniotic fluid cells.
    McLaughlin D; Tsirimonaki E; Vallianatos G; Sakellaridis N; Chatzistamatiou T; Stavropoulos-Gioka C; Tsezou A; Messinis I; Mangoura D
    J Neurosci Res; 2006 May; 83(7):1190-200. PubMed ID: 16555279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of GABA and GABA receptor inhibition on differentiation of mesencephalic precursors into dopaminergic neurons in vitro.
    Parga JA; Rodriguez-Pallares J; Guerra MJ; Labandeira-Garcia JL
    Dev Neurobiol; 2007 Oct; 67(12):1549-59. PubMed ID: 17525990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury.
    Park KI; Himes BT; Stieg PE; Tessler A; Fischer I; Snyder EY
    Exp Neurol; 2006 May; 199(1):179-90. PubMed ID: 16714016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.